Osteoporosis

Osteoporosis affects as many as 3 million people in the UK, with one third of adult women likely to suffer from an osteoporotic fracture in their lifetime.

Why is prevention important?

Osteoporosis is known as the silent disease because people are often unaware they have the condition until they break or fracture a bone, at which stage the disease can be significantly advanced. This means that it is extremely important that you detect osteoporosis as early as possible.

Synexus and Osteoporosis

Synexus is the world's largest multinational company dedicated to the successful recruitment and running of clinical studies. We also have a long and successful history of treating patients who have developed or are at risk of osteoporosis. We are also conducting a study in the area of osteoporosis that you may be interested in.

This study may be suitable for you if you:

  • are female and post-menopausal
  • are aged 45 to 85 years
  • have taken bisphosphonates for at least three years, including alendronate (fosamax) for the last year or longer 

If you are interested in participating in this study, please contact us on 0845 468 0919.

Participating Clinics

  1. Lancashire
  2. Manchester
  3. Merseyside
  4. Midlands
  5. Glasgow

More Information

Enrolment start date
17/12/2009
Enrolment end date
13/08/2010
Study reference code
MSDXXXOST012

Email alerts

If you are interested in receiving information about Synexus, please let us have your email address and we will send you up to date details.

Synexus Limited, Registered in England and Wales, Registered number 3724238, Registered Office: Sandringham House, Ackhurst Park, Chorley , Lancashire, PR7 1NY